These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1844692)

  • 1. Testing for consistency in a single multicenter trial.
    Chinchilli VM; Bortey EB
    J Biopharm Stat; 1991; 1(1):67-80. PubMed ID: 1844692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demonstration of the reproducibility of treatment efficacy from a single multicenter trial.
    Huster WJ; Louv WC
    J Biopharm Stat; 1992; 2(2):219-38. PubMed ID: 1300215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sample size calculation for multicenter randomized trial: taking the center effect into account.
    Vierron E; Giraudeau B
    Contemp Clin Trials; 2007 Jul; 28(4):451-8. PubMed ID: 17188941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sample size determination for hierarchical longitudinal designs with differential attrition rates.
    Roy A; Bhaumik DK; Aryal S; Gibbons RD
    Biometrics; 2007 Sep; 63(3):699-707. PubMed ID: 17825003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of the treatment difference in multicenter trials.
    Fedorov V; Jones B; Jones M; Zhigljavsky A
    J Biopharm Stat; 2004 Nov; 14(4):1037-63. PubMed ID: 15587979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Test homogeneity of odds ratio in a randomized clinical trial with noncompliance.
    Lui KJ; Chang KC
    J Biopharm Stat; 2009 Sep; 19(5):916-32. PubMed ID: 20183452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The analysis of continuous outcomes in multi-centre trials with small centre sizes.
    Pickering RM; Weatherall M
    Stat Med; 2007 Dec; 26(30):5445-56. PubMed ID: 17924360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sample size allocation to regions in a multiregional trial.
    Uesaka H
    J Biopharm Stat; 2009 Jul; 19(4):580-94. PubMed ID: 20183427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of homogeneity of treatment effect in adaptive multicenter clinical trials.
    Chen L; Tamura RN
    J Biopharm Stat; 1998 Mar; 8(1):55-67. PubMed ID: 9547427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing equality of correlations of two paired binary responses from two treated groups in a randomized trial.
    Pei Y; Tang ML; Wong WK; Tang NS
    J Biopharm Stat; 2011 May; 21(3):511-25. PubMed ID: 21442523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interval estimation of the proportion ratio in repeated binary measurements under a stratified randomized clinical trial with noncompliance.
    Lui KJ; Chang KC
    J Biopharm Stat; 2012; 22(1):109-32. PubMed ID: 22204530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Qualitative consistency of treatment effects in multiregional clinical trials.
    Tanaka Y; Li G; Wang Y; Chen J
    J Biopharm Stat; 2012 Sep; 22(5):988-1000. PubMed ID: 22946945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Bayesian analysis of institutional effects in a multicenter cancer clinical trial.
    Gray RJ
    Biometrics; 1994 Mar; 50(1):244-53. PubMed ID: 8086608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A web-based clinical trial management system for a sham-controlled multicenter clinical trial in depression.
    Durkalski V; Wenle Zhao ; Dillon C; Kim J
    Clin Trials; 2010 Apr; 7(2):174-82. PubMed ID: 20083496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of an outcome using trajectories estimated from a linear mixed model.
    Maruyama N; Takahashi F; Takeuchi M
    J Biopharm Stat; 2009 Sep; 19(5):779-90. PubMed ID: 20183443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninferiority testing beyond simple two-sample comparison.
    Tsong Y; Chen WJ
    J Biopharm Stat; 2007; 17(2):289-308. PubMed ID: 17365225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Order-restricted tests for stratified comparisons of binomial proportions.
    Agresti A; Coull BA
    Biometrics; 1996 Sep; 52(3):1103-11. PubMed ID: 8805770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new population-enrichment strategy to improve efficiency of placebo-controlled clinical trials of antidepressant drugs.
    Merlo-Pich E; Alexander RC; Fava M; Gomeni R
    Clin Pharmacol Ther; 2010 Nov; 88(5):634-42. PubMed ID: 20861834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Choice of delta noninferiority margin and dependency of the noninferiority trials.
    Tsong Y; Zhang J; Levenson M
    J Biopharm Stat; 2007; 17(2):279-88. PubMed ID: 17365224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.